Format

Send to:

Choose Destination
See comment in PubMed Commons below
Case Rep Ophthalmol. 2012 May;3(2):196-9. doi: 10.1159/000339656. Epub 2012 Jun 12.

Intravitreal bevacizumab for photodynamic therapy-induced massive macular detachment in acute central serous chorioretinopathy.

Author information

  • 1Department of Ophthalmology, University of Thessaly School of Medicine, Larissa, Greece.

Abstract

We present a long followed up case of acute central serous chorioretinopathy (CSC) complicated by a severe visual loss due to massive pigment epithelium detachment of the macula after a full-dose photodynamic therapy (PDT). Rapid anatomical and functional improvement was observed after a single intravitreal injection of bevacizumab. To our knowledge, we report the first case of PDT-treated CSC complicated by severe visual loss. We can only speculate that the serous detachment of the posterior pole might have been caused by PDT-induced VEGF overexpression, explaining such an impressive response to Avastin treatment.

KEYWORDS:

Bevacizumab; Central serous chorioretinopathy; Photodynamic therapy

PMID:
22740830
[PubMed]
PMCID:
PMC3383330
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for S. Karger AG, Basel, Switzerland Icon for PubMed Central
    Loading ...
    Write to the Help Desk